Nozomi Yamazaki;Joseph D. Rosenblatt;Eckhard R. Podack
发明人:
Eckhard R. Podack,Koichi Yamazaki,Joseph D. Rosenblatt
申请号：
US12921151
公开号：
US08475785B2
申请日:
2009.03.03
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Cell-based immunotherapy (e.g., immunization or vaccination) may be improved by frequent administration to a human subject of allogeneic cancer cells secreting a modified heat shock protein (e.g., gp96), depletion of B cells in the subject, or both. Antigen (e.g., epitope derived from neoantigen or tumor antigen of allogeneic or syngeneic cancer cells) may induce a specific immune response in the subject. For example, the epitope bound in an immunogenic complex with the secreted heat shock protein may be obtained from allogeneic cancer cells coexpressing both secreted gp96 and antigen, or from syngeneic cancer cells of the subject expressing only antigen.
